What is CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age 65 or older) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CURB-65: A Severity Assessment Tool for Community-Acquired Pneumonia

CURB-65 is primarily used to assess the severity of community-acquired pneumonia (CAP), predict mortality risk, and guide site-of-care decisions including hospital admission and ICU assessment. 1

Components and Scoring

CURB-65 evaluates five clinical parameters, with one point assigned for each:

  • Confusion (mental status change) 1
  • Urea >7 mmol/L (BUN >19 mg/dL) 1
  • Respiratory rate ≥30 breaths/minute 1
  • Blood pressure (systolic <90 mmHg or diastolic <60 mmHg) 1
  • Age 65 years or older 1

Risk Stratification and Clinical Application

The CURB-65 score correlates with mortality risk and guides treatment decisions:

Score Mortality Risk Recommended Management
0-1 0.7-2.1% Consider outpatient treatment [1]
2 9.2% Consider short hospital stay or supervised outpatient treatment [1]
3 14.5% Hospital admission, assess for ICU [1]
4-5 40-57% Hospital admission, assess for ICU [1]

Advantages of CURB-65

  • Simplicity: Uses only five variables compared to PSI's 20 variables, making it more practical in emergency settings 1, 2
  • Accessibility: Requires only one laboratory test (urea/BUN), which is readily available in most hospitals 1
  • Validated Performance: Effectively predicts mortality with an area under the curve of 0.77 3
  • Efficient Resource Allocation: Helps reduce unnecessary hospitalizations while ensuring appropriate care for higher-risk patients 1

Simplified Version: CRB-65

  • A variant that omits blood urea nitrogen testing (CRB-65) is available for settings where laboratory tests are not readily accessible 1, 2
  • CRB-65 is particularly useful in outpatient settings and resource-limited environments 1

Limitations and Considerations

  • CURB-65 may underestimate severity in young patients with severe respiratory failure and in elderly patients with comorbidities 1
  • The sensitivity of CURB-65 (score ≥2) for predicting critical care interventions is approximately 78.4%, indicating some high-risk patients may be missed 3
  • When used for ICU admission decisions, CURB-65 performs less effectively than criteria specifically designed for ICU triage, such as the IDSA/ATS severe CAP criteria 1, 2
  • A significant number of patients with CURB-65 scores ≤2 may still require ICU admission and critical care interventions 3

Comparison with Other Scoring Systems

  • The Pneumonia Severity Index (PSI) is more complex but similarly effective in predicting mortality 1, 4
  • PSI is primarily designed to identify low-risk patients who can be safely treated as outpatients 4, 2
  • Recent meta-analyses suggest CURB-65 may have slightly better performance in early mortality prediction and higher sensitivity (96.7%) and specificity (89.3%) for predicting ICU admission compared to PSI 5

Best Practices for Implementation

  • Use CURB-65 as an adjunct to clinical judgment, not as the sole determinant for site-of-care decisions 1
  • Consider implementing CURB-65 as part of a systematic approach to CAP severity assessment 1
  • For patients with CURB-65 scores ≥3, promptly evaluate for potential ICU admission 1
  • Exercise caution when using CURB-65 alone to guide disposition, as some patients with low scores may still require critical care interventions 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.